Your browser doesn't support javascript.
loading
SCFFBXW7 regulates G2-M progression through control of CCNL1 ubiquitination.
O'Brien, Siobhan; Kelso, Susan; Steinhart, Zachary; Orlicky, Stephen; Mis, Monika; Kim, Yunhye; Lin, Sichun; Sicheri, Frank; Angers, Stephane.
Afiliação
  • O'Brien S; Department of Biochemistry, University of Toronto, Toronto, ON, Canada.
  • Kelso S; Donnelly Centre for Cellular and Biomolecular Research, Toronto, ON, Canada.
  • Steinhart Z; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Orlicky S; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
  • Mis M; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
  • Kim Y; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
  • Lin S; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
  • Sicheri F; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
  • Angers S; Donnelly Centre for Cellular and Biomolecular Research, Toronto, ON, Canada.
EMBO Rep ; 23(12): e55044, 2022 12 06.
Article em En | MEDLINE | ID: mdl-36278408
FBXW7, which encodes a substrate-specific receptor of an SCF E3 ligase complex, is a frequently mutated human tumor suppressor gene known to regulate the post-translational stability of various proteins involved in cellular proliferation. Here, using genome-wide CRISPR screens, we report a novel synthetic lethal genetic interaction between FBXW7 and CCNL1 and describe CCNL1 as a new substrate of the SCF-FBXW7 E3 ligase. Further analysis showed that the CCNL1-CDK11 complex is critical at the G2-M phase of the cell cycle since defective CCNL1 accumulation, resulting from FBXW7 mutation, leads to shorter mitotic time. Cells harboring FBXW7 loss-of-function mutations are hypersensitive to treatment with a CDK11 inhibitor, highlighting a genetic vulnerability that could be leveraged for cancer treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclinas / Ubiquitina-Proteína Ligases / Proteína 7 com Repetições F-Box-WD Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclinas / Ubiquitina-Proteína Ligases / Proteína 7 com Repetições F-Box-WD Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article